Clinical Trial Update: Efficacy and Safety of SHR-3167 and Insulin Glargine in Type 2 Diabetes Subjects [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of SHR-3167 in combination with insulin glargine in adults with type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin Glargine (insulin glargine)
• SHR-3167

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Type 2 Diabetes | Phase 2 | Status: ACTIVE_NOT_RECRUITING